Vivani Medical(VANI) - 2022 Q4 - Annual Report

Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-36747 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Vivani Medical, Inc. (Exact name of registrant as specified in its charter) California (State or other jurisdic ...